Delic Announces Postponement of Meet Delic Conference
Meet Delic will now be held on October 14 and 15, 2023 in Las Vegas
Tickets purchased for Meet Delic 2022 will be honored at next year's event
VANCOUVER, BC, Sept. 6, 2022 /CNW/ - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced the postponement of the Meet Delic conference taking place November 5 and 6 at AREA15 in Las Vegas, Nevada. The conference will now be held on October 14 and 15, 2023, in the same location. Tickets purchased for 2022 Meet Delic will be honored at next year's event and current Early Bird pricing has been extended for an additional 30 days.
Delic's annual Meet Delic conference has emerged as the world's premier psychedelic wellness experience. More than 2,500 people visited AREA15 in Las Vegas, Nevada, last November to attend and experience two days of programs and activities, including 20 hours of talks, panels and discussions at the intersection of psychedelics, wellness, and business by over 60 thought leaders, medical professionals and wellness advocates.
The company plans to build upon the success of Meet Delic 2021 when it returns next year to AREA15 in Las Vegas. Delic will bring together thought and business leaders and health & wellness experts from across the globe to explore the past, present and future of psychedelics. The 2023 Meet Delic conference will also feature showstopping artists, musicians and entertainers. Past performers included Mindchatter, Little Miss Nasty, Sporeganic and DJ David Starfire.
"Meet Delic 2021 was the first event of its kind and brought awareness to the benefits of psychedelics to heal people and communities through enlightening panels and talks and electrifying performances. Next year promises to be a breakthrough year for the psychedelic renaissance, so we've decided the best way to celebrate is to move Meet Delic to 2023," said Matt Stang, executive chairman of Delic. "We're excited to bring the community together again next October to learn more about the groundbreaking opportunities within psychedelics to address the current mental health crisis. We look forward to unveiling what we have planned for Meet Delic 2023."
For more information regarding becoming a sponsor or attending the next Meet Delic Conference, please visit https://meetdelic.com/.
Ticket holders requesting a refund can find more info at https://meetdelic.com/refunds/.
Meet Delic is the world's premier psychedelic and wellness edutainment event catering to both curious newcomers, businesses and thought leaders. Held in AREA15, an immersive and experiential entertainment complex in the heart of Las Vegas, the exciting two-day event features industry entrepreneurs, consumers, psychonauts and leading voices in research and science. Meet Delic is the largest and most comprehensive event to learn about the intersection of psychedelics, health and wellness and culture, how to start or grow your business, connect with likeminded visionaries, enjoy fun social activities, and experience the acceleration of this worldwide movement.
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, Ketamine Wellness Centers; the only licensed entity by Health Canada to focus exclusively on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and better access to effective and affordable treatment options.
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Delic's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include, but are not limited to: information regarding the timing or terms upon which the Transaction will be completed; potential benefits of the Transaction; anticipated continued growth in the health and wellness sector (and, in particular, related to psychedelics); the ability of Delic to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, Delic is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Delic to be materially different from those expressed or implied by such information and statements. Such risks and other factors may include, but are not limited to: risks and uncertainties relating to the Transaction not closing as planned or at all or on terms and conditions set forth in the Merger Agreement; incorrect assessment of the value and potential benefits of the Transaction; direct and indirect material adverse effects from the COVID-19 pandemic; inability to obtain future financing on suitable terms; failure to obtain required regulatory and other approvals; risks inherent in the psychedelic treatment sector; changes in applicable laws and regulations; and failure to comply with applicable laws and regulations.
In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions. These assumptions include, but are not limited to: assumptions as to the time required to negotiate a definite agreement and complete matters related to the Transaction; the ability to consummate the Transaction; the ability of the parties to obtain, in a timely manner, the requisite regulatory, corporate and other third party approvals and the satisfaction of other conditions to the consummation of the Transaction on the proposed terms; the potential impact of the announcement or consummation of the Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the Transaction.
Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although Delic believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Delic does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Delic or persons acting on its behalf is expressly qualified in its entirety by this notice.
SOURCE Delic Holdings Inc.
Investor Relations Contact: Rich Rodriguez, [email protected]; Media Contact, MATTIO Communications, Clare Redlick, [email protected]
Share this article